Iryna Dyagil

2.0k total citations · 2 hit papers
57 papers, 1.3k citations indexed

About

Iryna Dyagil is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Iryna Dyagil has authored 57 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Genetics, 25 papers in Hematology and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Iryna Dyagil's work include Chronic Lymphocytic Leukemia Research (38 papers), Chronic Myeloid Leukemia Treatments (21 papers) and Acute Lymphoblastic Leukemia research (12 papers). Iryna Dyagil is often cited by papers focused on Chronic Lymphocytic Leukemia Research (38 papers), Chronic Myeloid Leukemia Treatments (21 papers) and Acute Lymphoblastic Leukemia research (12 papers). Iryna Dyagil collaborates with scholars based in Ukraine, United States and Italy. Iryna Dyagil's co-authors include Jörge E. Cortes, Dong‐Wook Kim, Carlo Gambacorti‐Passerini, Tim H. Brümmendorf, Laimonas Griškevičius, Hemant Malhotra, Karı̈n Gogat, Hagop M. Kantarjian, Christine Powell and Athena Countouriotis and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Environmental Health Perspectives.

In The Last Decade

Iryna Dyagil

51 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial

2012 344 citations Iryna Dyagil, Laimonas Griškevičius et al. profile →
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial

2017 320 citations Iryna Dyagil et al. profile →

Peers

Countries citing papers authored by Iryna Dyagil

Since Specialization

Citations

This map shows the geographic impact of Iryna Dyagil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iryna Dyagil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iryna Dyagil more than expected).

Fields of papers citing papers by Iryna Dyagil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iryna Dyagil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iryna Dyagil. The network helps show where Iryna Dyagil may publish in the future.

Co-authorship network of co-authors of Iryna Dyagil

This figure shows the co-authorship network connecting the top 25 collaborators of Iryna Dyagil. A scholar is included among the top collaborators of Iryna Dyagil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iryna Dyagil. Iryna Dyagil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	THE COURSE OF CHRONIC LYMPHOCYTIC LEUKEMIA AFTER SARS-COV-2 VIRUS INFECTION 2023 ·Проблеми радіаційної медицини та радіобіології = Problems of Radiation Medicine and Radiobiology ·Iryna Dyagil, (unknown), (unknown), (unknown), (unknown), (unknown), Chumak Aa, (unknown)	0
2	The signs of negative selection in IGHV framework regions are associated with worse overall survival of chronic lymphocytic leukemia patients 2021 ·Leukemia Research ·(unknown), (unknown), Chumak Aa, Iryna Kryachok, (unknown), (unknown), Iryna Dyagil	1
3	MYC copy number and mRNA expression in chronic lymphocytic leukemia patients exposed to ionizing radiation due to the Chornobyl NPP accident 2020 ·Experimental Oncology ·(unknown), (unknown), Chumak Aa, Iryna Dyagil, (unknown)	1
4	Analysis of immunoglobulin heavy variable chain rearrangement in chronic lymphocytic leukemia patients among Chornobyl clean-up workers 2020 ·Experimental Oncology ·(unknown), (unknown), Chumak Aa, Iryna Dyagil, (unknown)	2
5	THE INCIDENCE OF MULTIPLE MYELOMA IN THE DNIPROPETROVSK REGION 2019 ·Проблеми радіаційної медицини та радіобіології = Problems of Radiation Medicine and Radiobiology ·(unknown), (unknown), P. Özge Kaplan, Ganna Usenko, Irina Sidorenko, Iryna Dyagil	0
6	Novel Score-based Decision Approach in Chronic Myeloid Leukemia Patients After Acute Toxic Imatinib-induced Liver Injury 2019 ·Cureus ·(unknown), (unknown), (unknown), (unknown), Iryna Dyagil	4
7	Сase Report of Acute Toxic Imatinib-induced Hepatitis in a Patient with Chronic Myeloid Leukemia, Sulfa Allergy, and Rheumatoid Arthritis 2018 ·Cureus ·(unknown), Iryna Dyagil, (unknown), (unknown), (unknown), (unknown), (unknown)	4
8	Epidemiology of Late Health Effects in Ukrainian Chornobyl Cleanup Workers 2018 ·Health Physics ·D. Bаzyка, (unknown), Natalia Gudzenko, Iryna Dyagil, (unknown), V. Chumak, (unknown)	25
9	Clinical relevance of TP53 polymorphic genetic variations in chronic lymphocytic leukemia 2017 ·Leukemia Research ·(unknown), (unknown), Vladimir Saenko, Chumak Aa, Iryna Dyagil, (unknown), Iryna Kryachok	10
10	Buccal mucosa micronuclei counts in relation to exposure to low dose-rate radiation from the Chornobyl nuclear accident and other medical and occupational radiation exposures 2017 ·Environmental Health ·D. Bаzyка, Stuart C. Finch, (unknown), (unknown), Iryna Dyagil, (unknown), Natalia Gudzenko, V. Chumak, Kyle M. Walsh, J. Wiemels, Mark P. Little, Lydia B. Zablotska	12
11	Chronic Lymphocytic Leukemia in Chornobyl Cleanup Workers 2016 ·Health Physics ·D. Bаzyка, Natalia Gudzenko, Iryna Dyagil, (unknown), (unknown), (unknown), (unknown), (unknown)	7
12	A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia 2015 ·Leukemia & lymphoma ·Thomas J. Kipps, Herbert Eradat, Sebastian Grosicki, John Catalano, Walter Cosolo, Iryna Dyagil, Sreeni Yalamanchili, Akiko Chai, Srikumar Sahasranaman, Elizabeth A. Punnoose, Deborah Hurst, Halyna Pylypenko	151
13	Non-radiation risk factors for leukemia: A case-control study among chornobyl cleanup workers in Ukraine 2015 ·Environmental Research ·Natalia Gudzenko, Maureen Hatch, D. Bаzyка, Iryna Dyagil, (unknown), Alina V. Brenner, V. Chumak, (unknown), Lydia B. Zablotska, Kiyóhiko Mabuchi	11
14	Radiation and the Risk of Chronic Lymphocytic and Other Leukemias among Chornobyl Cleanup Workers 2012 ·Environmental Health Perspectives ·Lydia B. Zablotska, D. Bаzyка, Jay H. Lubin, Natalia Gudzenko, Mark P. Little, Maureen Hatch, Stuart C. Finch, Iryna Dyagil, Robert F. Reiss, V. Chumak, André Bouville, Vladimir Drozdovitch, Victor Kryuchkov, Ivan Golovanov, Elena Bakhanova, (unknown), (unknown), (unknown), (unknown), Kiyóhiko Mabuchi	105
15	CD38 gene polymorphism and risk of chronic lymphocytic leukemia 2012 ·Leukemia Research ·(unknown), (unknown), (unknown), Chumak Aa, Iryna Kryachok, (unknown), Iryna Dyagil	5
16	Molecular and clinical features of chronic lymphocytic leukemia with stereotyped B-cell receptors in a Ukrainian cohort 2010 ·Leukemia & lymphoma ·(unknown), Riccardo Bomben, Michele Dal Bo, Daniela Capello, Francesco Forconi, Luca Laurenti, Francesco Bertoni, Dimitar G. Efremov, Roberto Marasca, Giovanni Del Poeta, (unknown), (unknown), Iryna Dyagil, Gianluca Gaïdano, Chumak Aa, Valter Gattei, (unknown)	8
17	High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study 2010 ·Haematologica ·Andreas Petzer, Dominik Wolf‎, Dominic Fong, Thomas Lion, Iryna Dyagil, Zvenyslava Masliak, Andrija Bogdanović, Laimonas Griškevičius, Sandra Lejniece, Vesselina Goranova‐Marinova, Liana Gercheva, Dražen Stojanović, (unknown), Nikolay Tzvetkov, (unknown), (unknown), Hanno Ulmer, (unknown), (unknown), Günther Gastl	27
18	Hematological effects of protein kinases inhibitor maleimide derivative (1-(4 -Cl-benzyl)-3-Cl-4-(CF3-phenylamino)-1H-pyrrole-2,5-dione) 2010 ·Journal of Pre-Clinical and Clinical Research ·(unknown), Rybal'chenko Vk, (unknown), Iryna Dyagil	2
19	Chronic lymphocytic leukemia patients exposed to ionizing radiation due to the Chernobyl NPP accident—With focus on immunoglobulin heavy chain gene analysis 2007 ·Leukemia Research ·(unknown), (unknown), Chumak Aa, (unknown), Iryna Kryachok, (unknown), (unknown), Iryna Dyagil, D. Bаzyка, V. Bebeshko	26
20	Megakaryocytes morphology in idiopathic (primary) myelofibrosis 2004 ·Reports of Practical Oncology & Radiotherapy ·(unknown), (unknown), Iryna Dyagil	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact